Sort by
Refine Your Search
-
Employer
-
Field
-
gene repertoires, recombinant antibody development, and immunochemical analysis to study the evolution of such responses during therapy, in combination with assessment of clinical outcomes of the therapy
-
divergence, and the evolution of mutation and recombination rates. The successful candidate will also have the opportunity to be involved in these projects. We benefit from collaboration with the groups
-
positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 . The interviews will start in April/May 2026. For more information about AMBER, application and evaluation
Enter an email to receive alerts for recombinant "https:" positions